A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy

Published 2015 View Full Article

Authors

Keywords

Atherogenic dyslipidaemia, cardiovascular risk, cholesterol, combination therapy, fenofibrate, statins, triglycerides

Journal

ATHEROSCLEROSIS SUPPLEMENTS

Volume 19, Issue -, Pages 1-12

Publisher

Elsevier BV

Online

2015-08-24

DOI

10.1016/s1567-5688(15)30001-5

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started